Wego Intervention's Metal Drug-Eluting Stent System Receives Vietnam Medical Device Registration Certificate
Kinhely
Cardiovascular Interventional Device R&D and Production Company
Recently, the metal drug-eluting stent system independently developed by Kinhely Bio-Tech Co., Ltd., a subsidiary of Weigao Interventional Group, successfully passed the review by Vietnamese regulatory authorities and obtained the Vietnamese medical device registration certificate. This certification further enhances and expands the company's overseas market layout in Southeast Asia, broadens the enterprise's international development footprint, and lays a solid foundation for this product to establish itself in Southeast Asia and steadily expand into global overseas markets.
Weigao Interventional has always adhered to innovation-driven development, strictly aligning with international quality standards to establish a comprehensive standardized management system covering R&D, production, quality control, and compliance. The successful acquisition of market access qualifications in Vietnam serves as strong evidence of the company’s core competitiveness and international operational capabilities, highlighting its firm commitment to deeply cultivating the global medical market and serving patients both domestically and abroad. Looking ahead, the company will continue to strengthen its technological innovation capabilities, optimize product performance and quality, steadily advance its global strategic layout, and enhance the international influence of Chinese-made interventional medical devices, thereby accelerating the global expansion of national medical brands.
